| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $36.92B | $42.17B | $47.71B |
| YoY Revenue Growth % | -12.5% | -11.6% | — |
| Gross Profit | $947.8M | $1.03B | — |
| Gross Margin % | 2.6% | 2.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$564.7M | $210.6M | $198.0M |
| Operating Margin % | -1.5% | 0.5% | 0.4% |
| Net Income (GAAP) | -$614.4M | $67.4M | $52.9M |
| EBITDA (Normalized) | -$512.2M | $265.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $292.9M | $259.9M | $271.3M |
| Capital Expenditures (CapEx) | $65.6M | $68.2M | — |
| Free Cash Flow (FCF) | $227.3M | $191.7M | $271.3M |
| FCF Margin % | 0.6% | 0.5% | 0.6% |
| Return on Invested Capital (ROIC %) | -40.4% | 10.6% | — |
| Cash & Short-Term Equivalents | $193.5M | $382.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.30B | $1.95B | — |